Medicinova (MNOV) Share-based Compensation (2010 - 2025)
Medicinova's (MNOV) quarterly Share-based Compensation came in at -$648532.0 in Q4 2025, up 26.76% year-on-year from -$511629.6 in Q4 2024, and down 316.18% on a QoQ basis from $300000.0 in Q3 2025.
Medicinova (MNOV) Share-based Compensation (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Share-based Compensation data on file, last reported at -$648532.0 in Q4 2025.
- On a quarterly basis, Share-based Compensation rose 26.76% year-over-year to -$648532.0 in Q4 2025; TTM through Dec 2025 was -$1.0 million, a 2567.2% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, changed 0.0% from the prior year.
- Share-based Compensation for Q4 2025 stood at -$648532.0, down from $300000.0 in the prior quarter.
- Over the last five years, Share-based Compensation for MNOV reached as high as $1.1 million in Q1 2021 and fell as low as -$885466.0 in Q4 2024.
- Historically, Share-based Compensation has averaged $203222.4 across 5 years, with a median of $246822.0 in 2022.
- Across the five-year window, Share-based Compensation soared 397.53% in 2023 and sank 254.88% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at -$756972.0 in 2021, then soared by 117.0% to $128669.0 in 2022, then surged by 344.33% to $571709.0 in 2023, then sank by 254.88% to -$885466.0 in 2024, then climbed by 26.76% to -$648532.0 in 2025.
- Per Business Quant data, the three most recent Share-based Compensation figures were -$648532.0 in Q4 2025, $300000.0 in Q3 2025, and $204897.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | -648,532.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -648,532.00 |
| Dec 31, 2025 | -648,532.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 204,897.00 |
| Jun 30, 2025 | 204,897.00 |
| Mar 31, 2025 | 285,943.00 |
| Mar 31, 2025 | 285,943.00 |
| Dec 31, 2024 | -885,466.00 |
| Dec 31, 2024 | -885,466.00 |
| Sep 30, 2024 | 504,862.00 |
| Sep 30, 2024 | 504,862.00 |
| Jun 30, 2024 | 207,455.00 |
| Jun 30, 2024 | 207,455.00 |
| Mar 31, 2024 | 215,430.00 |
| Mar 31, 2024 | 215,430.00 |
| Dec 31, 2023 | 571,709.00 |
| Dec 31, 2023 | 571,709.00 |
| Sep 30, 2023 | 219,142.00 |
| Sep 30, 2023 | 219,142.00 |